KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$33.6 million.

  • BioNTech SE's Consolidated Net Income fell 11542.21% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$730.0 million, marking a year-over-year decrease of 69181.54%. This contributed to the annual value of -$710.9 million for FY2024, which is 14582.55% down from last year.
  • BioNTech SE's Consolidated Net Income amounted to -$33.6 million in Q3 2025, which was down 11542.21% from -$474.1 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Consolidated Net Income peaked at $7.2 billion during Q3 2021, and registered a low of -$865.6 million during Q2 2024.
  • Moreover, its 5-year median value for Consolidated Net Income was $934.5 million (2023), whereas its average is $1.9 billion.
  • In the last 5 years, BioNTech SE's Consolidated Net Income skyrocketed by 163746041825.11% in 2021 and then crashed by 31749.74% in 2024.
  • Quarter analysis of 5 years shows BioNTech SE's Consolidated Net Income stood at $7.2 billion in 2021, then tumbled by 67.54% to $2.3 billion in 2022, then tumbled by 59.81% to $934.5 million in 2023, then crashed by 70.32% to $277.3 million in 2024, then plummeted by 112.1% to -$33.6 million in 2025.
  • Its Consolidated Net Income stands at -$33.6 million for Q3 2025, versus -$474.1 million for Q2 2025 and -$499.6 million for Q1 2025.